<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-37168" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Breast Ultrasound</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Malherbe</surname>
            <given-names>Kathryn</given-names>
          </name>
          <aff>University of Pretoria</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Tafti</surname>
            <given-names>Dawood</given-names>
          </name>
          <aff>Brooke Army Medical Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Kathryn Malherbe declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dawood Tafti declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>1</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-37168.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Breast ultrasound is performed due to the high incidence rate of breast cancer amongst women globally. Ultrasound is typically used as an adjunct to mammographic imaging, which remains the gold standard for breast cancer diagnosis. The main indications for breast ultrasound include palpable breast mass,&#x000a0; dense fibroglandular breast tissue, and pregnant/lactating women. This activity reviews the methodology and assessment of breast ultrasound, emphasizing the interprofessional team's collaborative efforts in evaluating and recommending this procedure.</p>
        <p>Clinicians engaging in this activity can expect to&#x000a0;learn&#x000a0;the latest advancements in breast ultrasound and enhance their practical skills. This heightened proficiency is crucial in addressing the limitations posed by dense breast parenchyma on mammography.&#x000a0;Participants will navigate the lexicon of breast sonography, unraveling multiple descriptions of findings' features and refining their ability to make assessments based on the most concerning characteristics. With the latest knowledge and practical skills, clinicians will ensure a comprehensive approach to breast ultrasound that directly translates into improved patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the indications and contraindications of breast ultrasound.</p></list-item><list-item><p>Select appropriate imaging techniques, consider patient-specific factors, and coordinate with radiology teams to ensure optimal breast ultrasound procedures, minimizing false positives and negatives.</p></list-item><list-item><p>Implement standardized guidelines, such as those outlined in the 2013 ACR BI-RADS Atlas, to assess breast ultrasound findings consistently, fostering a uniform approach to interpretation and reporting.</p></list-item><list-item><p>Apply a multidisciplinary approach by collaborating with radiologists and other healthcare professionals on the interprofessional team, facilitating comprehensive breast disease evaluation and recommendations for further management.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=37168&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=37168">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-37168.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Breast ultrasound has developed into a practical solution for the evaluation of breast disease. Although mammography remains the gold standard for breast cancer screening, it presents certain imaging limitations with dense breast parenchyma. Due to this, ultrasound and magnetic resonance imaging (MRI) have been expanding their role as part of supplementary breast screening procedures.<xref ref-type="bibr" rid="article-37168.r1">[1]</xref></p>
        <p>The sensitivity for breast cancer detection using both mammography and ultrasound increases to 97.3%, with the false positive rate of ultrasound estimated as 2.4%.<xref ref-type="bibr" rid="article-37168.r2">[2]</xref></p>
        <p>Guidelines regarding breast sonography terminology are presented in the 2013 ACR BI-RADS Atlas. Multiple descriptions of breast findings' features, with a final assessment, often depend on the most concerning characteristic.&#x000a0;</p>
      </sec>
      <sec id="article-37168.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Breast ultrasound is often used to localize palpable and nonpalpable masses before surgical excision.<xref ref-type="bibr" rid="article-37168.r3">[3]</xref></p>
        <p>The basic breast anatomy comprises 15&#x000a0;to 20 lobules, each consisting of smaller breast ducts, known as the terminal duct lobular units (TDLUs).&#x000a0;All the ducts drain into a single lactiferous sinus towards the nipple.</p>
        <p>The three main anatomical zones of the breast are the premammary, mammary, and retromammary zones, which consist of fatty, fibroglandular, and muscular tissue. Breast fat and fibroglandular tissue lie between the superficial fascia immediately deep to the skin and the deep fascial layer superficial to the pectoralis muscle.&#x000a0;</p>
        <p>From a sonographic point of view, the breast is divided into various hypoechoic and hyperechoic layers (see <bold>Image.</bold>&#x000a0;Sonographic Cross-Sectional View of Benign Breast Tissue with Typical Hyperechoic, Hypoechoic Layers of Skin, Fat, Fibroglandular and Muscle):</p>
        <list list-type="bullet">
          <list-item>
            <p>Skin (hyperechoic, white fibrous bands)</p>
          </list-item>
          <list-item>
            <p>Fat (hypoechoic, subcutaneous fat lobules)</p>
          </list-item>
          <list-item>
            <p>Breast parenchyma (hyperechoic, fibroglandular soft tissue)</p>
          </list-item>
          <list-item>
            <p>Retromammary fat (hypoechoic fat lobules)</p>
          </list-item>
          <list-item>
            <p>Pectoralis major muscle (hyperechoic fibrous tissue)&#x000a0;<xref ref-type="bibr" rid="article-37168.r4">[4]</xref></p>
          </list-item>
        </list>
        <p>The axilla's anatomy is important in evaluating nodal disease and biopsy planning. The axilla contains lymph nodes and the axillary artery and vein. Normal lymph nodes demonstrate an echogenic fatty hilum, with hypoechoic cortices measuring less than 3 mm (see <bold>Images.</bold> Right Axillary Biopsy Proven Malignant Lymph Node with Cortical Thickening of 6 mm and&#x000a0;Biopsy Proven Malignant Left Axillary Lymph Node with Cortical Thickening of 5 mm).&#x000a0;</p>
        <p>The axillary and subclavian arteries supply blood to the breast via the internal mammary (internal thoracic), lateral thoracic, and thoracoacromial artery branches. Most&#x000a0;lymphatic drainage empties into the ipsilateral axillary nodal basin, while the internal mammary chain provides a small percentage of the drainage. As a rule of thumb, the ipsilateral axillary nodes provide 90% of the lymphatic drainage and 10% to the internal mammary chain. Contralateral breast drainage after a surgical course, such as in the setting of a mastectomy, is an uncommon but well-described phenomenon.<xref ref-type="bibr" rid="article-37168.r5">[5]</xref></p>
      </sec>
      <sec id="article-37168.s4" sec-type="Indications">
        <title>Indications</title>
        <p>Common indications for breast ultrasound include the following:&#x000a0;<xref ref-type="bibr" rid="article-37168.r6">[6]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Palpable lump during clinical breast evaluation</p>
          </list-item>
          <list-item>
            <p>Axillary lymphadenopathy present on mammogram imaging</p>
          </list-item>
          <list-item>
            <p>Women younger than 40 years with the clinical presentation of certain anomalies</p>
          </list-item>
          <list-item>
            <p>Pregnant or lactating women</p>
          </list-item>
          <list-item>
            <p>Suspicious abnormality identified on mammogram imaging</p>
          </list-item>
          <list-item>
            <p>Nipple discharge</p>
          </list-item>
          <list-item>
            <p>Skin retraction or inversion of the nipple</p>
          </list-item>
          <list-item>
            <p>Surgical scarring evident&#x000a0;on mammogram imaging</p>
          </list-item>
          <list-item>
            <p>Gynecomastia</p>
          </list-item>
          <list-item>
            <p>Suspicion of ruptured breast implants used to differentiate between intra- and extra-capsular ruptures</p>
          </list-item>
          <list-item>
            <p>Needle-guided percutaneous breast biopsy</p>
          </list-item>
          <list-item>
            <p>Follow-up&#x000a0;of patients receiving neoadjuvant chemotherapy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-37168.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>The use of breast ultrasound as a sole screening tool is inappropriate.<xref ref-type="bibr" rid="article-37168.r7">[7]</xref></p>
      </sec>
      <sec id="article-37168.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>High-frequency ultrasound has improved over the past decade with standard linear frequency probes ranging from 7.5 MHz to 23 MHz, with high-density or single crystal probe components, which improves lateral resolution. Tissue harmonic imaging (THI) is also a standard feature of most entry-level ultrasound units for reducing reverberation and near-field artifacts. Real-time compound scanning aids in improved contrast resolution. Overall, a linear array transducer with a center frequency of at least 10 MHz is recommended by the ACR, with higher frequency transducers best utilized for high-resolution images and lower frequency utilized for deep tissue penetration and in patients with large breasts. A&#x000a0;high-resolution, real-time, linear-array, broad-bandwidth transducer operating at a center frequency of a minimum of 12 MHz, preferably higher, should be used for breast ultrasounds.</p>
        <p>An appropriate field of view should be obtained during the sonographic assessment of the breast. Panoramic imaging provides an increased longitudinal imaging perspective of breast lesions in relation to the surrounding breast tissue and can be employed in larger lesions or the setting of multiple lesions. Additional techniques include image splicing for large lesions and volumetric acquisitions, enabling 3D image generation.&#x000a0;</p>
        <p>The latest technology from ultrasound vendors now also boasts stand-alone linear frequency probes connecting wirelessly to mobile imaging application software.<xref ref-type="bibr" rid="article-37168.r8">[8]</xref></p>
        <p>Most ultrasound software allows computer-aided detection (CAD) to assist in segmenting and identifying suspicious mass lesions. This technology allows for increased improvement in diagnostic proficiency.</p>
        <p>Proper technical consideration is required to produce quality ultrasound images, such as the depth of the focal zone, time gain compensation measures, and overall gain used during mass lesion assessment.<xref ref-type="bibr" rid="article-37168.r9">[9]</xref>&#x000a0;The focal zone should be placed within the anterior third or middle third of the region between the chest wall and the skin. Regarding the gray-scale setting, the subcutaneous fat lobules should appear medium gray as opposed to hypoechoic or anechoic. Setting the gain to be high can make some cysts appear solid. Compound imaging used by averaging multiple ultrasound images can be utilized to improve the resolution and assessment of lesion margins.</p>
      </sec>
      <sec id="article-37168.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>Breast ultrasound is performed by an ultrasound technician, radiologist, or a referring clinician with adequate technical and clinical competency for ultrasound evaluation.</p>
      </sec>
      <sec id="article-37168.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>Breast ultrasound is a noninvasive procedure with none or very little special preparation required. Jewelry in the anatomical region of interest should be removed, and the patient is encouraged to wear loose clothing and undress the upper half of the torso before the examination.<xref ref-type="bibr" rid="article-37168.r10">[10]</xref></p>
      </sec>
      <sec id="article-37168.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>Initial breast imaging of the patient should include a full clinical breast self-examination (BSE) to assess and validate all palpable masses identified by the patient or physician. Following BSE, a bilateral breast ultrasound is performed sequentially, sweeping the breast surface.</p>
        <p>The breast is assessed in the&#x000a0;4 main quadrants: outer upper, outer inner, lower outer, and lower inner quadrants. Any lesions identified during the examination should be marked as a breast 'o clock position for future follow-up sessions.</p>
        <p>The most common imaging technique is radial, star-shaped, or superior to inferior sweep of the entire breast, extending to the axillary space, parasternal, and clavicular surfaces.</p>
        <p>The retroareolar space should also be evaluated systematically; the dense tissue causes posterior acoustic shadowing, limiting visibility posterior to its surface. This anatomical limitation can be overcome by either angling the probe upwards towards the retroareolar ducts or using a gel standoff pad with a decreased focal zone and altering the tissue gain compensation controls, visualizing the soft tissue posterior to the dense nipple tissue.<xref ref-type="bibr" rid="article-37168.r11">[11]</xref></p>
        <p>When measuring a lesion, the longest axis of a lesion should be measured, and units should be recorded to the nearest millimeter or centimeter. Three measurements of a lesion should be given, with the largest measurement representing the longest axis of the interrogated lesion. The second measurement should include a measurement perpendicular to the longest axis, and the third measurement should be obtained in an orthogonal view to the first 2, representing a different plane of the lesion in question.</p>
        <p>Breasts vary in their fat and fibroglandular tissue composition. The categories based on tissue composition include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Homogenous background echotexture - fat
<list list-type="bullet"><list-item><p>Fat comprises the majority of breast tissue in this category</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Homogenous background echotexture - fibroglandular
<list list-type="bullet"><list-item><p>Consists of echogenic fibroglandular parenchyma beneath normal fat</p></list-item></list>
</p>
          </list-item>
          <list-item>
            <p>Heterogenous background echotexture
<list list-type="bullet"><list-item><p>Consists of varying degrees of echogenicity, which can obscure lesions</p></list-item></list>
</p>
          </list-item>
        </list>
        <p>When assessing masses, the following descriptors need to be incorporated in the reporting and final assessment of a lesion:</p>
        <list list-type="bullet">
          <list-item>
            <p>Shape: oval, round or irregular</p>
          </list-item>
          <list-item>
            <p>Oriental: parallel or not parallel</p>
          </list-item>
          <list-item>
            <p>Margin: circumscribed or not circumscribed (further characterized as indistinct, angular, microlobulated, or spiculated)</p>
          </list-item>
          <list-item>
            <p>Echo pattern: anechoic, hyperechoic, complex cystic and solid, hypoechoic, isoechoic, heterogenous</p>
          </list-item>
          <list-item>
            <p>Posterior features: No posterior features (see <bold>Image.</bold>&#x000a0;Findings Demonstrating an Oval, Parallel, Circumscribed, Hypoechoic Mass with No Discernable Posterior Features), enhancement, shadowing (see <bold>Image.</bold>&#x000a0;Biopsy Proven Atypical Ductal Hyperplasia), combined pattern(mixed enhancement and shadowing)&#x000a0;</p>
          </list-item>
        </list>
        <p>If calcifications are present, their location should be described to include whether they are located in a mass, outside a mass, or intraductal. Associated features of sonographic findings should also be evaluated for including architectural distortion, skin thickening or retraction, absence or presence of vascularity (rim or internal), changes of the associated ducts, and if applicable, assessment of elasticity as soft, intermediate, or hard. Certain findings have a pathognomonic appearance, including simple cysts (see <bold>Image.</bold> Simple Cyst of the Left Breast), clustered microcysts, complicated cysts, masses associated with the skin (in or on the skin), foreign bodies, lymph nodes, and vascular abnormalities such as Mondor disease, and arteriovenous malformations. Based on clinical history, seromas, and fat necrosis can also be confidently assessed on ultrasound.</p>
      </sec>
      <sec id="article-37168.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Breast ultrasound is a safe, non-invasive procedure without any complications of the procedure itself.</p>
      </sec>
      <sec id="article-37168.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Ultrasound as part of follow-up imaging for masses reported as breast imaging reporting and data system (BI-RADS) 2 or 3 (probably benign) has shown great value in assessing morphological changes to the sonographic appearance.</p>
        <p>Using ultrasound as a standard follow-up imaging tool can promote the recharacterization of lesions during initial imaging assessment.</p>
        <p>A complete ultrasound examination requires recording results in a standard breast report, including the patient's indications, findings, and results with differential diagnoses.</p>
        <p>Any lesions noted during the examination should be measured in both transverse and longitudinal planes. The location, measurement, and echogenicity of all masses should be described as either hypoechoic, hyperechoic, or heterogeneous.</p>
        <p>The various mass descriptors are used according to the ultrasound breast imaging and reporting system (US BIRADS) lexicon, which includes&#x000a0;6 main morphological descriptors for breast masses:&#x000a0;<xref ref-type="bibr" rid="article-37168.r12">[12]</xref></p>
        <p>The most common morphologic features associated with benign sonographic findings are:&#x000a0;<xref ref-type="bibr" rid="article-37168.r13">[13]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Smooth and well-circumscribed margins</p>
          </list-item>
          <list-item>
            <p>Hyperechoic, isoechoic, or mildly hypoechoic in echogenicity</p>
          </list-item>
          <list-item>
            <p>Thin echogenic capsule or well-defined capsule border</p>
          </list-item>
          <list-item>
            <p>Ellipsoid shape, wider than tall appearance</p>
          </list-item>
          <list-item>
            <p>Macrolobulated; less than 3&#x000a0;lobulated margins</p>
          </list-item>
          <list-item>
            <p>Posterior acoustic enhancement</p>
          </list-item>
        </list>
        <p>The most common morphologic features associated with malignant findings are as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Hypoechoic mass, on occasion, hyperechoic in appearance (see <bold>Image.&#x000a0;</bold>Ultrasound Image of a Right Breast Mass)</p>
          </list-item>
          <list-item>
            <p>Spiculated margins</p>
          </list-item>
          <list-item>
            <p>Ill-defined borders, architectural distortion of surrounding soft tissue</p>
          </list-item>
          <list-item>
            <p>Posterior acoustic shadowing</p>
          </list-item>
          <list-item>
            <p>Taller than wide appearance</p>
          </list-item>
          <list-item>
            <p>Microcalcifications present&#x000a0;<xref ref-type="bibr" rid="article-37168.r14">[14]</xref></p>
          </list-item>
        </list>
        <p>Clinically significant fibroglandular tissue in males typically presents as a palpable "flame-shaped" focal area of fibroglandular tissue that is retroareolar in location. Hormonal effects of certain medications, including illicit drug use, often stimulate the growth of the otherwise rudimentary breast tissue in males (see <bold>Image.&#x000a0;</bold>Left Breast Palpable Abnormality in a Male Representative of Gynecomastia).</p>
        <p>When reporting a breast ultrasound,&#x000a0;pertinent components should be included in the report as follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Indication for the study</p>
          </list-item>
          <list-item>
            <p>Comparison to previous studies when applicable</p>
          </list-item>
          <list-item>
            <p>The technique used during the exam (to include the scope of interrogated tissue, positioning of the patient if notable to lesion identification, use of Doppler imaging, and use of 3D imaging if applicable) (see <bold>Image.&#x000a0;</bold>Ultrasound Image of the Patient's Area of Palpable Concern in the Right Breast Demonstrates a Superficial Vein with a Focal Area of Absent Intraluminal Flow on Doppler Interrogation)</p>
          </list-item>
          <list-item>
            <p>A brief description of breast composition</p>
          </list-item>
          <list-item>
            <p>Appropriate description of a finding to include sonographic features, size, and location</p>
          </list-item>
          <list-item>
            <p>BI-RADS assessment (0 or 1 to 6)</p>
          </list-item>
          <list-item>
            <p>Management/recommendations regarding the need for follow-up, biopsy, or other clinical management decisions</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-37168.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Healthcare professionals, including physicians, advanced care practitioners, nurses, pharmacists, and others, should possess advanced skills in interpreting breast ultrasound findings, recognizing nuances in imaging, and applying the latest techniques. This involves ongoing education to stay abreast of technological advancements and evolving guidelines, ensuring accurate assessments.&#x000a0;As part of interprofessional education (IPE), point of care ultrasound (POCUS) has been expanding over many medical specialties.</p>
        <p>Effective communication is fundamental. Professionals must engage in open dialogue, sharing insights, findings, and concerns to facilitate a cohesive team approach. Health professionals must also collaborate to create integrated care pathways, ensuring that patients move smoothly through the continuum of breast health, from screening to diagnosis and, if necessary, treatment.&#x000a0;For full&#x000a0;interprofessional collaboration, role clarification of each practitioner should be assessed. Conflict resolution methods between learner and practitioner should be provided for the best outcomes.</p>
        <p>Collaborative strategic planning is crucial to align breast ultrasound practices across disciplines. Developing standardized protocols, updating guidelines, and incorporating evidence-based strategies collectively contribute to a cohesive and efficient approach to breast disease evaluation. Healthcare professionals can collectively enhance patient-centered care, improve outcomes, ensure patient safety, and optimize team performance in breast ultrasound.</p>
      </sec>
      <sec id="article-37168.s13" sec-type="Nursing, Allied Health, and Interprofessional Team Monitoring">
        <title>Nursing, Allied Health, and Interprofessional Team Monitoring</title>
        <p>Pre-workshop assessments should include demographics as well as the attitudes of healthcare professionals regarding the use of IPE (see <bold>Image.</bold> Interprofessional Education in Breast Ultrasound). During training and collaborative teaching events, simulation of activities can promote increased awareness and interest in ultrasound imaging. Following workshop integration, a follow-up regarding attitudes of IPE should be encouraged to assess if the resulting work leads to contextual learning and assessment across all fields of medicine.</p>
      </sec>
      <sec id="article-37168.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=37168&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=37168">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/37168/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=37168">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-37168.s15">
        <fig id="article-37168.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Interprofessional education in breast ultrasound Contributed by K Malherbe</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="ipe1" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-37168.s16">
        <fig id="article-37168.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Sonographic cross-sectional view of benign breast tissue with typical hyperechoic, hypoechoic layers of skin, fat, fibroglandular and muscle. Contributed by Dr P Schoub, Parklane Radiology, SA</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="benign__cross____section__" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-37168.s17">
        <fig id="article-37168.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Ultrasound image of a right breast mass. Biopsy proven ductal carcinoma. Contributed by Dawood Tafti, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="biopsy__proven__metastasis" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-37168.s18">
        <fig id="article-37168.image.f4" position="float" orientation="portrait">
          <caption>
            <p>Right axillary biopsy proven malignant lymph node with cortical thickening of 6 mm. Contributed by Dawood Tafti, MD.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="right__axillary__suspicious__node" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-37168.s19">
        <fig id="article-37168.image.f5" position="float" orientation="portrait">
          <caption>
            <p>Biopsy proven malignant left axillary lymph node with cortical thickening of 5 mm. Vascularity of the hilum and the periphery is noted. Dawood Tafti, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="suspeicious__axilalry__node" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-37168.s20">
        <fig id="article-37168.image.f6" position="float" orientation="portrait">
          <caption>
            <p>Simple cyst of the left breast. Contributed by Dawood Tafti, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="cyst" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-37168.s21">
        <fig id="article-37168.image.f7" position="float" orientation="portrait">
          <caption>
            <p>Left breast palpable abnormality in a male representative of gynecomastia. Sonographic image is at the level of the left nipple which is shadowing (appropriately so). Retroareolar hypoechogenicity represents the gynecomastia in question. Contributed by Dawood Tafti, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Dendritic__gynecomastia" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-37168.s22">
        <fig id="article-37168.image.f8" position="float" orientation="portrait">
          <caption>
            <p>Biopsy proven atypical ductal hyperplasia. Sonographic features of an irregular, parallel mass with indistinct borders and characterized by hypoechogenicity. Posterior features reflective of shadowing is also noted. Together these findings are suspicious. Contributed by Dawood Tafti, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="atypical__ductal__hyperplasia" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-37168.s23">
        <fig id="article-37168.image.f9" position="float" orientation="portrait">
          <caption>
            <p>Findings demonstrating an oval, parallel, circumscribed, hypoechoic mass with no discernable posterior features. Together these findings are consistent with a fibroadenoma. Contributed by Dawood Tafti, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="fibroadenoma__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-37168.s24">
        <fig id="article-37168.image.f10" position="float" orientation="portrait">
          <caption>
            <p>Ultrasound image of the patient's area of palpable concern in the right breast demonstrates a superficial vein with a focal area of absent intraluminal flow on Doppler interrogation. Contributed by Hassana Barazi, MD.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Picture2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-37168.s25">
        <title>References</title>
        <ref id="article-37168.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Esmaeili</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ayyoubzadeh</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Ahmadinejad</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ghazisaeedi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Nahvijou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maghooli</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>A decision support system for mammography reports interpretation.</article-title>
            <source>Health Inf Sci Syst</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>8</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <pub-id pub-id-type="pmid">32257128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Berg</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Reducing Unnecessary Biopsy and Follow-up of Benign Cystic Breast Lesions.</article-title>
            <source>Radiology</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>295</volume>
            <issue>1</issue>
            <fpage>52</fpage>
            <page-range>52-53</page-range>
            <pub-id pub-id-type="pmid">32073379</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Toyoda</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Premaratne</surname>
                <given-names>ID</given-names>
              </name>
              <name>
                <surname>Chiuzan</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rohde</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Affordable Care Act State-Specific Medicaid Expansion: Impact on Health Insurance Coverage and Breast Cancer Screening Rates.</article-title>
            <source>J Am Coll Surg</source>
            <year>2020</year>
            <month>Mar</month>
            <day>03</day>
            <pub-id pub-id-type="pmid">32272206</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gokhale</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Ultrasound characterization of breast masses.</article-title>
            <source>Indian J Radiol Imaging</source>
            <year>2009</year>
            <season>Jul-Sep</season>
            <volume>19</volume>
            <issue>3</issue>
            <fpage>242</fpage>
            <page-range>242-7</page-range>
            <pub-id pub-id-type="pmid">19881096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wellner</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dave</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Menes</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Altered lymphatic drainage after breast-conserving surgery and axillary node dissection: local recurrence with contralateral intramammary nodal metastases.</article-title>
            <source>Clin Breast Cancer</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>7</volume>
            <issue>6</issue>
            <fpage>486</fpage>
            <page-range>486-8</page-range>
            <pub-id pub-id-type="pmid">17386126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mendelson</surname>
                <given-names>EB</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>WA</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>PB</given-names>
              </name>
            </person-group>
            <article-title>Benefits of Supplemental Ultrasonography With Mammography.</article-title>
            <source>JAMA Intern Med</source>
            <year>2019</year>
            <month>Aug</month>
            <day>01</day>
            <volume>179</volume>
            <issue>8</issue>
            <fpage>1150</fpage>
            <pub-id pub-id-type="pmid">31380949</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Evans</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Trimboli</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Athanasiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Balleyguier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baltzer</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Bick</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Camps Herrero</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Clauser</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Colin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cornford</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fallenberg</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Fuchsjaeger</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Helbich</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Kinkel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Heywang-K&#x000f6;brunner</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kuhl</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Martincich</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Panizza</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pediconi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pijnappel</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Pinker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Zackrisson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Forrai</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sardanelli</surname>
                <given-names>F</given-names>
              </name>
              <collab>European Society of Breast Imaging (EUSOBI) , with language review by Europa Donna&#x02013;The European Breast Cancer Coalition</collab>
            </person-group>
            <article-title>Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging.</article-title>
            <source>Insights Imaging</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>9</volume>
            <issue>4</issue>
            <fpage>449</fpage>
            <page-range>449-461</page-range>
            <pub-id pub-id-type="pmid">30094592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Prenta&#x00161;ic</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Heisler</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mammo</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Merkur</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Navajas</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Beg</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>&#x00160;arunic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Loncaric</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Segmentation of the foveal microvasculature using deep learning networks.</article-title>
            <source>J Biomed Opt</source>
            <year>2016</year>
            <month>Jul</month>
            <day>01</day>
            <volume>21</volume>
            <issue>7</issue>
            <fpage>75008</fpage>
            <pub-id pub-id-type="pmid">27401936</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bick</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Trimboli</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Athanasiou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Balleyguier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Baltzer</surname>
                <given-names>PAT</given-names>
              </name>
              <name>
                <surname>Bernathova</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Borb&#x000e9;ly</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Brkljacic</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Carbonaro</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Clauser</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Cassano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Colin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Esen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Evans</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fallenberg</surname>
                <given-names>EM</given-names>
              </name>
              <name>
                <surname>Fuchsjaeger</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Gilbert</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Helbich</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Heywang-K&#x000f6;brunner</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Herranz</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kinkel</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kilburn-Toppin</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kuhl</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Lesaru</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lobbes</surname>
                <given-names>MBI</given-names>
              </name>
              <name>
                <surname>Mann</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Martincich</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Panizza</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pediconi</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pijnappel</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Pinker</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Schiaffino</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sella</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Thomassin-Naggara</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Tardivon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ongeval</surname>
                <given-names>CV</given-names>
              </name>
              <name>
                <surname>Wallis</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Zackrisson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Forrai</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Herrero</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Sardanelli</surname>
                <given-names>F</given-names>
              </name>
              <collab>European Society of Breast Imaging (EUSOBI), with language review by Europa Donna&#x02013;The European Breast Cancer Coalition</collab>
            </person-group>
            <article-title>Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging.</article-title>
            <source>Insights Imaging</source>
            <year>2020</year>
            <month>Feb</month>
            <day>05</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>12</fpage>
            <pub-id pub-id-type="pmid">32025985</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaminsky</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Abdul Halim</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zilbermints</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Sharon</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Aranovich</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Young Woman in the Breast Clinic: Ultrasound or Not?</article-title>
            <source>Isr Med Assoc J</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>21</volume>
            <issue>9</issue>
            <fpage>612</fpage>
            <page-range>612-614</page-range>
            <pub-id pub-id-type="pmid">31542907</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pushkin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Berg</surname>
                <given-names>WA</given-names>
              </name>
            </person-group>
            <article-title>Differences in Breast Density Awareness, Knowledge, and Plans.</article-title>
            <source>J Gen Intern Med</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>35</volume>
            <issue>8</issue>
            <fpage>2472</fpage>
            <pub-id pub-id-type="pmid">32221857</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tutar</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Esen Icten</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guldogan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kara</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ar&#x00131;kan</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Tutar</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Uras</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Comparison of automated versus hand-held breast US in supplemental screening in asymptomatic women with dense breasts: is there a difference regarding woman preference, lesion detection and lesion characterization?</article-title>
            <source>Arch Gynecol Obstet</source>
            <year>2020</year>
            <month>May</month>
            <volume>301</volume>
            <issue>5</issue>
            <fpage>1257</fpage>
            <page-range>1257-1265</page-range>
            <pub-id pub-id-type="pmid">32215718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Flory</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>L&#x000e9;vy</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Viotti</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Schiappa</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Elkind</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Ghez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Pellegrin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Occelli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Dejode</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Delpech</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fouch&#x000e9;</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Figl</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Machiavello</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Haudebourg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Peyrottes</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Chapellier</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barranger</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>[Preoperative breast imaging review: Interests and limits of specialized validation in oncology].</article-title>
            <source>Bull Cancer</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>107</volume>
            <issue>3</issue>
            <fpage>295</fpage>
            <page-range>295-307</page-range>
            <pub-id pub-id-type="pmid">32115178</pub-id>
          </element-citation>
        </ref>
        <ref id="article-37168.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vincent-Salomon</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bataillon</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Djerroudi</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>[Hereditary breast carcinomas pathologist's perspective].</article-title>
            <source>Ann Pathol</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>40</volume>
            <issue>2</issue>
            <fpage>78</fpage>
            <page-range>78-84</page-range>
            <pub-id pub-id-type="pmid">32241645</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
